Subcutaneous (SC) refers to administration of a substance into the tissue layer between the skin and the muscle (subcutis). This is a common route of administration for peptides in research settings, offering slower absorption than intravenous (IV) but generally faster than intramuscular (IM) injection.

Key Points

  • Absorption Rate: Slower than IV, faster than IM
  • Onset: Typically 15-30 minutes for many peptides
  • Duration: Often 2-4 hours depending on peptide
  • Common Sites: Abdomen, thigh, upper arm
  • Volume Limits: Typically 1-2 mL per injection site

Research Context

In peptide research, subcutaneous administration is frequently studied because it:

  • Mimics common clinical administration routes
  • Provides consistent, measurable absorption profiles
  • Allows for controlled, sustained release in many formulations
  • Is less invasive than IV but more convenient than IM for self-administration in research models

Safety Considerations

  • Injection technique and site rotation are important to prevent tissue damage
  • Absorption rates can vary significantly between individuals
  • Local reactions (redness, swelling) are common in research settings
  • Sterile technique is essential to prevent infection

Note: This term describes an administration route, not a recommendation. Always follow approved protocols and institutional guidelines for research procedures.